Literature DB >> 1110992

The use of prostaglandin E1 to enhance the angiographic visualization of the splanchnic circulation.

L J Davis, J H Anderson, S Wallace, C Gianturco, E D Jacobson.   

Abstract

Superior mesenteric angiograms were obtained in a series of dogs before and again after the injection of a 1-ml bolus of prostaglandin E1 (0.1-1.0 mug/kg) through the angiographic catheter. The prostaglandin E1 produced, on the average, a 100% increase in the superior mesenteric arterial blood flow with only minimal changes in the heart rate, systemic arterial pressure, and portal venous pressure. Opacification of the portal venous system was consistently enhanced after the prostaglandin E1. The arterial phase was preserved by increasing the rate of contrast administration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1110992     DOI: 10.1148/114.2.281

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Human jejunal secretion induced by prostaglandin E1: a dose-response study.

Authors:  I Sobhani; N Vidon; B Huchet; J C Rambaud
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

2.  Effects of a rapid injection into the canine superior mesenteric artery of diatrizoate meglumine and diatrizoate sodium (Renografin-76).

Authors:  E D Jacobson; C Eldon; J D Fondacaro
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

3.  Nonocclusive intestinal ischemia treated with intraarterial infusion of prostaglandin E1.

Authors:  G Tyler; R A Clark; E D Jacobson
Journal:  Cardiovasc Intervent Radiol       Date:  1982       Impact factor: 2.740

4.  Indirect portography enhanced by nicardipine versus prostaglandin E1.

Authors:  Y Inoue; H Nakamura; H Akaji; K Yamasaki
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Mar-Apr       Impact factor: 2.740

5.  Control of the splanchnic circulation.

Authors:  E D Jacobson
Journal:  Yale J Biol Med       Date:  1977 May-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.